RE:RE:RE:ONCY Presented Positive GOBLET Pancreatic Cancer Data @ ESMOThe FDA instituted its Accelerated Approval Program to allow for earlier approval of drugs that treat serious conditions, and fill an unmet medical need based on a surrogate endpoint. A surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign or other measure that is thought to predict clinical benefit but is not itself a measure of clinical benefit. The use of a surrogate endpoint can considerably shorten the time required prior to receiving FDA approval.
https://www.fda.gov/drugs/nda-and-bla-approvals/accelerated-approval-program